Design Therapeutics, Inc. (DSGN)
NASDAQ · Healthcare
Design Therapeutics, Inc. EPS 2020–2025
Design Therapeutics, Inc. annual/quarterly eps history and growth rate from 2024 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Design Therapeutics, Inc. eps for the quarter ending March 31, 2026 was $0.29, a 6.45% decrease year-over-year.
- Design Therapeutics, Inc. annual eps for 2025 was $1.22, a 38.64% increase from 2024.
- Design Therapeutics, Inc. annual eps for 2024 was $0.88.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Design Therapeutics, Inc. EPS — FAQ
Design Therapeutics, Inc. (DSGN) eps over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Design Therapeutics, Inc.'s eps?
Design Therapeutics, Inc. (DSGN) reported eps of $-1.22 for fiscal 2025.
Where can I see DSGN's eps history?
The chart and table above show Design Therapeutics, Inc.'s eps by year and by quarter, including the growth rate.